Protect Info for Off-Patent Brands Even after Market Exit: JEMA

JEMA Chairman Hiroshi Matsumori The Japan Established Medicine Association (JEMA) on May 25 issued a proposal calling for the creation of a clear rule to protect and continue to provide information pertaining to off-patent brand-name medicines even after they withdraw...read more